Cutaneous toxicities of cancer therapy

被引:64
|
作者
Alley, E [1 ]
Green, R [1 ]
Schuchter, L [1 ]
机构
[1] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA
关键词
D O I
10.1097/00001622-200203000-00012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review highlights the cutaneous side effects associated with the administration of chemotherapy and discusses the management of these conditions. Rapidly growing cells are the targets of chemotherapy, so the skin, hair follicles, and nail matrix are frequently affected by chemotherapy. Chemotherapy skin reactions are more likely toxic than allergic reactions. The most common cutaneous reactions are alopecia, hyperpigmentation, hand-foot syndrome, radiation recall, hypersensitivity, extravasation injuries, and nail dystrophies. While these side effects are generally not life threatening, they can be a source of significant distress to patients, especially alopecia. (C) 2002 Lippincott Williams Wilkins, Inc.
引用
收藏
页码:212 / 216
页数:5
相关论文
共 50 条
  • [41] Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities
    Zaorsky, Nicholas G.
    Keith, Scott W.
    Shaikh, Talha
    Nguyen, Paul L.
    Horwitz, Eric M.
    Dicker, Adam P.
    Den, Robert B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (04): : 409 - 415
  • [42] Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) therapy in patients with advanced breast cancer: a single-centre experience
    Chawla, S.
    Parton, M.
    Johnston, S.
    Fearfield, L.
    Heelan, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 136 - 137
  • [43] Novel imaging paradigms for characterization of cardiovascular toxicities associated with cancer therapy
    DeCara, Jeanne
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 17
  • [44] Radiation therapy toxicities
    Harris, D
    King, GK
    Bergman, PJ
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1997, 27 (01) : 37 - &
  • [45] The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients
    Ra, H. S.
    Shin, S. J.
    Kim, J. H.
    Lim, H.
    Cho, B. C.
    Roh, M. R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (01) : e53 - e59
  • [46] Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience
    Sumir Chawla
    Alison Hill
    Louise Fearfield
    Stephen Johnston
    Marina Parton
    Kara Heelan
    Breast Cancer Research and Treatment, 2021, 188 : 535 - 545
  • [47] Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience
    Chawla, Sumir
    Hill, Alison
    Fearfield, Louise
    Johnston, Stephen
    Parton, Marina
    Heelan, Kara
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (02) : 535 - 545
  • [48] Cutaneous Toxicities in Breast Cancer Patients Receiving Chemotherapy and Targeted Agents-An Observational Clinical Study
    Anoop, T. M.
    Joseph, Rona P.
    Mini, P. N.
    Pranab, K. R.
    Gopan, Gayatri
    Chacko, Steffi
    CLINICAL BREAST CANCER, 2021, 21 (04) : E434 - E447
  • [49] Cutaneous Toxicities With Amivantamab for Non-Small Cell Lung Cancer: A Practical Guide and Best Practices
    Singh-Kandah, Shahnaz
    Wang, Kaiwen
    Xia, Karen
    Johnson, Andy Lain
    D'Andrea, Denise M.
    Shu, Catherine A.
    Dougherty, Lindsay Bray
    Gallitano, Stephanie M.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2024, 28 (06) : 559 - 566
  • [50] Prospective assessment of cutaneous toxicities and treatment interruptions of the association radiotherapy - cetuximab for head and neck cancer patients
    Barriere, J.
    Thariat, J.
    Chamorey, E.
    Benezery, K.
    Giacchero, D.
    Hebert, C.
    Poissonnet, G.
    Bozec, A.
    Follana, P.
    Peyrade, F.
    EJC SUPPLEMENTS, 2009, 7 (02): : 482 - 482